Class action lawsuits
The Rosen Law Firm, a global investor rights law firm, reminds investors who purchased Neogen Corporation's common stock between January 5, 2023, and June 3, 2025, of the impending September 16, 2025, lead plaintiff deadline. This deadline is crucial for those who may be entitled to compensation without
Class action lawsuits
Purchasers of Replimune securities between November 22, 2024, and July 21, 2025, may be entitled to compensation due to alleged false and misleading statements made by the company's defendants. A securities class action lawsuit has been filed, and a lead plaintiff must be appointed by September 22, 2025,
Class action lawsuits
Capricor Therapeutics, Inc. (NASDAQ: CAPR) has been involved in a class action securities lawsuit alleging securities fraud, filed on behalf of shareholders who suffered losses between October 9, 2024, and July 10, 2025. The complaint alleges that defendants provided investors with misleading information regarding Capricor's lead cell therapy
Class action lawsuits
iRobot Corporation has been the subject of a class action securities lawsuit, filed on behalf of investors who suffered losses due to alleged securities fraud. The lawsuit alleges that the company made false statements and/or concealed information about the restructuring plan, the company's ability to operate as
Class action lawsuits
Investors who purchased Hims & Hers Health, Inc. securities between April 29, 2025, and June 23, 2025, are reminded of the August 25, 2025 deadline to file a lead plaintiff motion in the class action filed on their behalf. The lawsuit alleges that the company made false and/or misleading
Class action lawsuits
In a recent development, Levi & Korsinsky, LLP has notified investors in XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (NYSE: XIFR) of a class action securities lawsuit. The lawsuit seeks to recover losses on behalf of investors who were allegedly adversely affected by securities fraud between September
Class action lawsuits
A class action lawsuit was filed against Novo Nordisk A/S for alleged securities fraud between May 7, 2025, and July 28, 2025. The lawsuit seeks to recover losses of shareholders who were adversely affected by allegedly false and misleading statements about the company's growth potential. Novo Nordisk&
Class action lawsuits
Purchasers of Hims common stock between April 29, 2025, and June 23, 2025, may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm, a global investor rights law firm, reminds investors of the important August 25, 2025, lead
Class action lawsuits
Neogen Corporation, a leading provider of genetics testing solutions, has been at the center of a class action lawsuit filed by investors alleging that the company made false and misleading statements about its integration process. Despite the company's initial assurances of a smooth integration, investors claim that they
Class action lawsuits
Altimmune investors who lost money on the stock between August 10, 2023, and June 25, 2025, may be able to recover their losses through a class action lawsuit filed against the company over alleged securities fraud. The lawsuit stems from Altimmune's announcement of topline results from the IMPACT
Class action lawsuits
Investors in Alto Neuroscience, Inc. may be affected by alleged securities fraud, and a class action lawsuit seeks to recover losses on their behalf. The lawsuit concerns investors who purchased Alto common stock in connection with the company's initial public offering on February 2, 2024, or acquired the
Class action lawsuits
A securities class action lawsuit has been filed against Alto Neuroscience, Inc. (NYSE: ANRO) alleging that the company made materially false and misleading statements regarding its business, operations, and prospects. The lawsuit claims that investors suffered damages due to the Company's false and/or misleading statements about the
